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Abstract Evolution persistently undermines vector control programs through insecticide
resistance. Here we propose a novel strategy which instead exploits evolution to generate and
sustain new control tools. Effective spatial repellents are needed to keep vectors out of houses.
Our approach generates such new repellents by combining a high-toxicity insecticide with a
candidate repellent initially effective against only part of the vector population. By killing
mosquitoes that enter treated properties the insecticide selects for vector phenotypes deflected
by the repellent, increasing efficacy of the repellent against the target vector population and in
turn protecting the insecticide against the spread of insecticide resistance. Using such evolved
spatial repellents offers an evolutionarily sustainable, ‘double-dip’ system of disease control
combining mortality and repellence. We formalize this idea using models which explore vector
population genetics and disease transmission probabilities and show that using evolved spatial
repellents is theoretically achievable, effective and sustainable.
DOI: 10.7554/eLife.15416.001
Introduction
Vector-borne diseases including malaria and dengue remain a major burden to human health despite
decades of funding targeting their eradication. One child per minute still dies of malaria globally
(WHO, 2015a), and dengue infects an estimated four hundred million individuals per year
(Bhatt et al., 2013; Murray et al., 2013). One of the key reasons for this has been the impact of
evolution on our control tools, with both theory and experience pointing to the inevitability of resis-
tance to conventional insecticides (Brogdon and McAllister, 1998; Hemingway et al., 2002;
Nauen, 2007; Asidi et al., 2012; Hemingway and Ranson, 2000; Ndiath et al., 2012). It is clear
that mosquito populations have considerable potential to evolve and that to achieve sustainable
control, it would be prudent to develop approaches that take evolution into account. Very funda-
mentally, there is a need for evolutionarily rational disease intervention (Boots, 2015). Here, we
highlight a potential intervention strategy in which evolution in the vector may be utilized to improve
rather than reduce disease control. Specifically, we argue that combining initially limited repellents
with toxic insecticides has the potential to select for effective repellence and to lead to evolutionarily
sustainable control using evolved spatial repellents (‘ESR’s).
It is important to understand that substances can affect vectors in multiple ways (Kennedy, 1947;
Miller et al., 2009) and there is considerable overlap in the terms used to describe their different
actions. We adopt the terminology of Greico et al. (Grieco et al., 2007) who characterize three
modes of action for the insecticides used in vector control programs; toxicity, contact-irritance and
spatial repellence. Toxicity is simply the capacity to generate mortality in mosquitoes that contact
the insecticide. Contact-irritance is the repellence of mosquitoes when they contact the insecticide,
and spatial repellence acts at a distance, deflecting mosquitoes before they contact a treated sur-
face. Specifically, we are considering repellence that acts to protect people indoors by preventing
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malaria vectors from entering treated properties, rather than more localized repellent effects that
might deflect them away from individuals outdoors or from treated surfaces indoors. The two
approaches are distinct, localized repellence from treated bednets, for example, provides protection
only for individuals with nets, and only at times of day when they are under the nets.
In the absence of resistance, DDT, the most effective chemical used to date for the control of
malaria vectors, has both high toxicity and high spatial repellence (Kennedy, 1947; Grieco et al.,
2007). Work inspired by the historic efficacy of DDT as a tool in combating malaria has highlighted
the potential role of spatial repellence as a means of reducing transmission (Achee et al., 2012;
Loyola et al., 1990; Roberts et al., 2000; Roberts, 2010; Roberts et al., 2000; Curtis, 2002;
Roberts and Alecrim, 1991). The malaria vectors targeted by public health campaigns using bed-
nets and indoor residual spraying of insecticides (IRS) typically feed indoors between dusk and
dawn. Vector control has therefore focused on exploiting this behaviour to deliver lethal control
measures against indoor-feeding mosquitoes (Yakob et al., 2011; WHO, 2015b), with outdoor bit-
ing viewed as unwanted behavioural resistance (Bradley et al., 2012; Russell et al., 2011;
Reddy et al., 2011; Cooke et al., 2015; Mouchet et al., 1963; Gatton et al., 2013; Killeen et al.,
2011). However, it is increasingly being acknowledged that a switch away from indoor biting, by
reducing vector fitness and/or by creating a less favourable context for transmission, may offer pub-
lic health benefits as an end in itself, consistent with the idea that the efficacy of DDT may be partly
derived from its repellent rather than solely its toxic effects (Roberts et al., 2000; Roberts, 1993;
Grieco et al., 2000). The use of spatial repellents as a tool to maintain vector-free homes is there-
fore now being actively investigated as a means of reducing transmission of malaria and dengue
(Achee et al., 2012; N’Guessan et al., 2006; Ogoma et al., 2014; University of Notre Dame,
2016). This can be viewed as an alternative means to achieve the same benefits as the application of
physical barriers to prevent vector access to homes (Roll Back Malaria, 2015; Patrick, 1900;
eLife digest Many of the mosquito species that transmit malaria have evolved to bite humans
indoors at night, and therefore health programs target them using insecticides sprayed on surfaces
inside people’s homes. This strategy, however, stops working when mosquito populations evolve to
resist the insecticide used, either because they are immune to its poisonous effects or because they
change their behaviour to avoid it. Consequently, there is now a need to develop alternative
strategies to control mosquitoes that are more sustainable in the face of evolution. One possibility is
repellents that keep mosquitoes out of homes.
Lynch and Boots have now asked whether evolution could be used to create effective repellents
from substances that initially repel only part of the mosquito population by pairing them with lethal
insecticides sprayed inside people’s homes. Mathematical models showed that, before insecticide
resistance becomes widespread, this “evolved repellence” approach could reduce the spread of
malaria by a similar amount to using insecticides alone. This was particularly true if the models
considered that, as well as surviving to give fewer infectious bites, repelled infectious mosquitoes
may be less likely to transmit malaria with each feed, for example if they feed more on livestock
rather than humans.
The models of Lynch and Boots also show that that the success of the evolved repellence concept
in a given location depends on a number of factors. The proportion of the starting mosquito
population that is repelled or resistant can have a large effect. Similarly, success will also depend on
how likely normal, repelled and insecticide-resistant mosquitoes are to reproduce successfully. These
values can be influenced by the choice of insecticide and repellent and how the chemicals are
applied. Lynch and Boots show that swapping insecticides can allow an evolved repellent to be
established where it would otherwise not succeed. Also, the spread of resistance to the paired
insecticide is slowed or prevented when the mosquito population evolves to be repelled.
Practical laboratory and field- work is now needed to build on this theoretical groundwork and to
determine suitable locations and application strategies to exploit this concept as a way to
sustainably reduce the spread of malaria in the future.
DOI: 10.7554/eLife.15416.002
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Menger et al., 2016). Syafruddin et al. have conducted a proof-of-concept double-blind placebo-
controlled field trial using spatial repellents disbursed from burning coils. This trial recorded an
approximately 50% reduction in malaria infections in repellent-protected properties
(Syafruddin et al., 2014). They emphasize the need for repellents able to achieve the same effects
without combustion in order to develop practical public health interventions. Given the benefits of
insect repellence in terms of nuisance reduction as well as disease control, and the consequent long-
standing interest in identifying safe and effective repellents, the limited choice and efficacy of cur-
rently available compounds suitable for this purpose suggests that finding suitable new repellent
substances is a particularly challenging task. Although many promising potential repellents are being
evaluated for personal protection, for localized outdoor and indoor protection, and for the prop-
erty-scale protection relevant for ESRs (Syafruddin et al., 2014; Govella et al., 2015; Abiy et al.,
2015; Revay et al., 2013; Mu¨ller et al., 2009), sustained, effective action at a distance is still chal-
lenging to achieve, and still often requires active dispersal through combustion or powered devices
(Revay et al., 2013; Mu¨ller et al., 2009). DDT itself carries a reputational burden from its historic
overuse, such that environmental concerns make its continued use problematic and its continued
availability uncertain.
We propose that for the vectors currently targeted by IRS campaigns, there is an opportunity to
exploit the evolutionary processes generated by using lethal insecticides to create effective new spa-
tial repellents from compounds that initially repel only a fraction of the vector population. Specifi-
cally, we propose a combination of a spatial repellent, which deters mosquitoes from entering
buildings, with a low-contact-repellence high-toxicity insecticide, which kills those which do enter,
leading to a ‘double-dip’ system of disease control. If failure to enter buildings is seen as a method
of transmission reduction in its own right, then the repellent provides transmission reduction by
deflecting mosquitoes. For mosquitoes that are not deflected, the mortality imposed by contact
with the insecticide will provide transmission reduction in the same manner as current insecticide-
only IRS control methods. Provided that, in a given context, the fitness cost of being deflected is
less than the fitness cost of being susceptible to the insecticide, there is potential for selection to
favour an increase in the proportion of deflected individuals in the treated population. If deflection
is viewed as a form of ‘behavioural resistance’, this system actively exploits ‘resistance’ evolution, as
mortality generated by the insecticide serves to select for phenotypes that are deflected by the
repellent. Candidates for use as spatial repellents thus only need initially to repel a small proportion
of a mosquito population, since in this instance, for once, evolution will work to enhance the efficacy
of a disease-control measure. Here, we explore the feasibility of this approach using evolutionary
models that explore a wide range of possible vector characteristics and disease parameters.
Modeling
If deflecting mosquitoes from accessing humans indoors is in itself an effective means of reducing
transmission, as proposed by Achee et al. (2012), then selection for mosquitoes which are repelled
from treated houses could serve to generate new public health tools. Critically, selection would
depend on the relative fitness of mosquitoes that are deflected away from buildings compared to
those entering buildings. This in turn would depend on the proportion of properties treated with
insecticides, the susceptibility or resistance (physiological) of mosquitoes contacting indoor insecti-
cides and the fitness costs associated with being deflected away from the sleeping indoor hosts
which vector species have evolved to exploit. However, the fitness costs of being deflected from
human dwellings are difficult to determine directly. Following a well-established history of mathe-
matical modeling to explore issues relating to the evolution of resistance in malaria vector popula-
tions (for example [Rosenheim and Tabashnik, 1990; Le Menach et al., 2007; Mandal et al., 2011;
Georghiou and Taylor, 1977; White et al., 2014]), we have therefore developed an analysis to
explore the possible outcome across a range of fitness scenarios, using a feeding-cycle based, two-
locus, bi-allelic population genetics model, capturing the mosquito life-history characteristics of one
initial mating and pre-adult development period as well as the Plasmodium development period in
infected mosquitoes before transmission is possible.
As well as the spread of resistance and deflection alleles over time, our model also tracks adult
population size and the expected number of infectious bites given by the population during each
modeled time unit. Each modeled time unit corresponds to the length and reproductive outcomes
of a single feeding cycle, an approach used in previous models of vector population genetics
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(Lynch et al., 2012; Read et al., 2009). For details of the model see Appendix 1. To minimize the
sensitivity of the model results to specific parameter values, we frame our key disease control results
in terms of the proportionate difference between the model’s calculated infectious bite values for a
given set of intervention assumptions and those assuming no intervention, minimising the impact of
parameter values that are unaffected by the intervention. The impact of deflection on malaria preva-
lence is determined by the proportion of mosquitoes deflected by a repellent and the probability
(compared to non-deflected mosquitoes) that they will then acquire and transmit a Plasmodium
infection. The effect on Plasmodium transmission of deflecting vectors to outdoor biting has not
been definitively measured in the field, we therefore consider a wide range of per-feed probabilities
of Plasmodium transmission to deflected mosquitoes compared to the 4% probability assumed for
indoor feeds. Reductions in this parameter are intended to represent the effects of all potential sour-
ces of reduced transmission to the vector, including deflection to non-human and therefore non-
infectious hosts. In terms of model results, proportionate reductions in this parameter will have the
same effect as proportionate changes in the probability that an infectious mosquito which survives
to feed will give an infectious bite to a human host. As such, the reductions explored can be inter-
preted as the product of the proportionate reductions in transmission to and from outdoor-feeding
vectors.
Our key model assumptions. (1) Physiological insecticide resistance is controlled by a single locus
bi-allelic autosomal gene, with the resistance allele being completely dominant to the susceptibility
allele. (2) Deflection by a given spatial repellent is controlled by a single locus bi-allelic autosomal
gene, with the deflection allele being completely dominant to the non-deflection allele. (3) Deflected
vectors are assumed not to come into contact with the insecticide used in association with the
ESR; therefore, mosquitoes that have phenotypes which combine deflection and resistance will not
experience any of the fitness benefits associated with resistance if the ESR and insecticide are always
present together. (4) The resistance and deflection loci are not linked and re-assort randomly. (5)
The genotypes determining adult resistance and deflection phenotypes do not affect the probability
of juvenile survival from egg to adult. (6) Mating is random and females mate once, as newly
emerged adults, with males in their cohort. (7) Juvenile density dependence means that variation in
the absolute number of eggs produced by the adult population does not materially change the rate
at which new adults join the population.
Whilst we cannot predict the form that the genetic determinants of resistance, behavioural or oth-
erwise, may take, there are examples of single-locus insecticide-resistance genes, including the
knockdown resistance (kdr) alleles that provide resistance to DDT and pyrethroids (Ndiath et al.,
2012; Chandre et al., 2000; Jones et al., 2012; Dabire´ et al., 2012). Whilst the genetic basis of
deflection behaviour is unknown and may often be more complex than that of insecticide resistance,
it is parsimonious to model this process initially by assuming simple single genes that determine the
likelihood of such responses. The impact on the predictions of continuous traits, or, should suitable
data become available, of specific more complex genetic assumptions, can be incorporated into
future work. The model considers four possible phenotypes, as shown in Table 1, with associated
genotypes (resistance alleles represented by R, and deflection alleles by D).
The average fitness of offspring into which deflection alleles are inherited, FD, is
FD ¼ FSþ
½Dr½ Rþ ½DR
½D 
ðFRD FSÞþ
½Dr½ r
½D 
ðFD FSÞ (Equation 1)
Table 1. Phenotype definitions and characteristics.
Phenotype Fitness Resistant Deflected Genotypes
Susceptible FS No No rr\dd
Resistant FR Yes No Rr\dd RR\dd
Deflected and not resistant FD No Yes rr\Dd rr\DD
Deflected and resistant FRD Yes Yes Rr\Dd Rr\DD
RR\Dd RR\DD
DOI: 10.7554/eLife.15416.003
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With ½dr; ½dR; ½Dr; ½DR; ½d  and D ½  representing, in the zygote genotypes for the population at
a given time point, the proportion of alleles at the deflection locus which are non-deflection alleles
paired with susceptible alleles, non-deflection alleles paired with resistant alleles, deflection alleles
paired with susceptible alleles, deflection alleles paired with resistant alleles, non-deflection alleles
paired with any resistance allele, and deflection alleles paired with any resistance allele, respectively,
assuming the same proportions in gametes of mating males and newly emerged females.
The average fitness of offspring into which non-deflection alleles are inherited, Fd, is
Fd ¼ FSþ ½dR 1þ
½dr
½d 
 
ðFR FSÞþ
½dr½Dr
½d 
ðFD FSÞþ ½DRþ
½dR½Dr
½d 
 
ðFRD FSÞ (Equation 2)
In order for the proportion of deflection alleles in the population to increase, we need the average
fitness of the offspring into which deflection alleles are inherited to be greater than the average fit-
ness of the offspring into which non-deflection alleles are inherited. This is true when the following
inequality applies:
FD>Fd $
½dr2
½d 
ðFD FSÞ>½dR 1þ
½dr
½d 
 
ðFR FDÞ
þ ½DR 1 
1
½D 
 
þ ½Dr
½dR
½d 
 
½ R
½D 
  
ðFRD FDÞ
(Expression 1)
The equivalent expression for spread of the resistance allele is:
FR >Fr $ ½rdðFR FSÞþ ½rDðFR FDÞþ ½rDþ
½RD½ d
½R 
 
½Rd½rD
½r 
 
ðFRD FRÞ
>
½rd½rD
½r 
ðFD FSÞ
(Expression 2)
See Appendix 2 for derivation of Equations 1 and 2 and Expressions 1 and 2.
We assume that ESR is only relevant where the fitness cost of being susceptible to an IRS insecti-
cide is greater than the fitness cost of being deflected by an ESR, so FD>FS, requiring that the mor-
tality associated with a mosquito that has a susceptible phenotype entering an insecticide-treated
property is greater than that associated with a mosquito being deflected from a property. From
Expression 1, it can be seen that the spread of the deflection allele in the vector population will be
favoured by maximising the fitness difference between susceptible and deflected phenotypes
(increasing the value of the left-hand side of the expression), and by maximising the fitness of
deflected relative to resistant phenotypes (reducing the value of the right-hand side of the expres-
sion). Avoiding the use of ESR in properties without insecticide, minimising Y3 (Table 2), and using
ESR in all insecticide-treated properties, minimising Y2, improves the survival of deflected pheno-
types (given B<I ) without affecting the survival probability of susceptible or resistant mosquitoes,
Table 2. Feeding related survival probabilities.
Feeding-related survival probabilities
Proportion of properties Y1 Y2 Y3 Y4
Phenotype Baseline fitness
adjustment
Untreated property Insecticide only ESR
only
Insecticide
and ESR
Average survival
Susceptible U U   I U U   I U   IðY2 þ Y4Þ
Resistant COR1 U U U U U
Resistant and deflected COR2 U U U   B U   B U   BðY3 þ Y4Þ
Deflected U U   I U   B U   B U   IY2   BðY3 þ Y4Þ
U=no-treatment survival, I=survival reduction caused by insecticide in susceptible mosquitoes, B=survival reduction caused by deflection from pro-
tected building, Yi=proportion of properties in each treatment category, COR1=fitness cost of resistance experienced by resistant non-deflected pheno-
types, COR2=fitness cost of resistance experienced by resistant deflected phenotypes.
DOI: 10.7554/eLife.15416.004
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enhancing the desired fitness relationships and hence favouring the spread of deflection alleles in
the vector population and the initial establishment of a new evolved spatial repellent.
From Expression 1, it can be seen that the spread of deflection alleles is dependent not only
upon the relative fitness values of the different phenotypes but also upon there being sufficiently
low initial levels of resistance alleles in the population. Since the genotype proportions will change
over time, this is a dynamic relationship. In order for the D allele to spread at all, initial allele propor-
tions and fitness relationships must comply with the inequality in Expression 1, but the spread of
the resistance allele over time may eventually reverse the relationship, so that the proportion of non-
deflection alleles will begin to increase instead. The rate of spread of the resistance allele will also
determine whether the deflection allele will spread and be sustained in the population. From
Expression 2, which shows the conditions necessary for the resistance allele to spread, it can be
seen that the fitness differential between resistant and susceptible phenotypes and that between
resistant and deflected-resistant phenotypes, by helping to determine whether the resistance alleles
spread, are also determinants of whether the deflection allele, and hence deflected phenotypes, will
spread and be maintained in the population. The spread of the deflection allele when resistance
alleles are present in the population is also critically determined by the initial proportion of deflec-
tion alleles at the deflection locus and by the proportions of deflection and non-deflection alleles
that are paired with resistance alleles. These interactions are explored in Figures 1–4.
In the absence of resistance, Expression 1 reduces to FD>Fd $ d ½  FD   FSð Þ>0, so deflection
would be expected to spread to fixation provided that deflected phenotypes have greater fitness
than non-deflected phenotypes. If deflection reaches fixation, then Expression 2 reduces to
FR>Fr $ ½rDðFRD   FDÞ>0, and resistance will only spread if resistant-deflected phenotypes are fit-
ter than deflected phenotypes. In this instance, the strategy of using ESR in all insecticide-treated
properties would prevent further spread of resistance because deflected mosquitoes would not
enter any insecticide-treated properties and would experience no benefits from resistance. hence
the fitness of resistant deflected phenotypes will be the same as or lower than that of non-resistant
deflected phenotypes (depending upon cost of resistance), giving FRD  FD.
Results
We carried out a numerical analysis using the model to explore the establishment over time of a new
ESR and the associated population-level changes in infectious bite rate. Assumed baseline parame-
ter values are: (i) time from egg laying to adult emergence equivalent to the length of three gonotro-
phic cycles, (ii) probability per feed that a non-deflected mosquito will acquire a Plasmodium
infection is 4%, (iii) probability per feed that an infectious mosquito gives an infectious bite on a
human host is 80%, (iv) time to infectiousness of Plasmodium infection in the vector is approximately
equivalent to the length of three gonotrophic cycles. Where not stated otherwise, we use 20% sur-
vival of susceptible phenotypes per cycle, 60% survival of resistant phenotypes per cycle, 45% sur-
vival of deflected phenotypes per cycle, 0.5% initial proportion of resistance alleles and 25% initial
proportion of deflection alleles.
The first question considered is whether, and under what circumstances, selection could generate
an effective spatial repellent from a substance that initially repelled only a part of the population.
Consistent with Expression 1, we found that the spread of a deflection allele through the population
depended on the initial proportions of deflection and resistance alleles in the population and the fit-
ness differentials between susceptible, resistant, deflected and resistant deflected phenotypes.
As illustrated in Figure 1, for some combinations of fitness values and initial allele proportions,
the deflection allele spreads rapidly to near-fixation, and remains consistently at that level for at least
300 cycles (panels labelled ‘a’). In other cases, the deflection allele spreads initially, but falls away
within 300 cycles as the resistance allele spreads (panels labelled ‘b’), and in some cases the deflec-
tion allele shows only minimal spread before being lost as resistance spreads (panels labelled ‘c’).
For cases like that in ‘b’, where deflection spreads initially but then falls away, we considered the
outcome if the insecticide used is swapped for an alternative, for which resistance alleles are still rel-
atively rare, whilst the deflection allele is close to its peak prevalence. In some cases this allows a
‘ratchet’ effect, whereby the deflection allele is able to spread and reach sustained high levels.
There is presently little or no direct information available about the fitness costs of a switch to
outdoor biting. Furthermore, this would be expected to vary with mosquito species, the degree of
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anthropophilly, the type and accessibility of outdoor hosts, and various other factors. The initial pro-
portion of deflection and resistance alleles in the population will depend upon the choice of insecti-
cide and ESR, but will also be expected to vary between specific populations. We therefore carried
out analyses for a range of parameter values, the results of which are summarized in Figure 2.
A comparison of panels (i) to (iv) in Figure 2 shows that the fitness values for all phenotypes, and
the initial prevalence of deflection and resistance alleles all affect the potential for deflection alleles
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Figure 1. Spread of deflection in a population over time. (i) Phenotype and (ii) genotype proportions over time for a population subject to insecticide
interventions applied in combination with an ESR. Illustrating (a) long-term establishment of ESR, (b) transient establishment of ESR, and (c) failure to
establish ESR. The parameter values used to generate the plots in panels (a) are: 20% per cycle survival of susceptible phenotypes, 60% per cycle
survival of resistant phenotypes 45% per cycle survival of deflected phenotypes, 0.5% initial proportion of resistance alleles and 25% initial proportion of
deflection alleles. For the panels in (b) and (c) , the per cycle survival of deflected phenotypes is reduced to 40%. For panel (c), other parameters are
also amended to 30% per cycle survival for susceptible phenotypes, 5% initial prevalence of resistance alleles and 10% initial prevalence of deflection
alleles.
DOI: 10.7554/eLife.15416.005
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Figure 2. Combinations of per cycle survival values for deflected and non-deflected resistant phenotypes, which support the spread and maintenance
of deflected phenotypes in the population. Grid plots indicating which combinations of resistant (x-axis) and deflected (y-axis) phenotype per-cycle
survival values (in 1% increments) give rise to a population comprising at least 80% deflected phenotypes after 300 modeled time periods. When this is
achieved directly, the applicable square is bright green. Dark green squares indicate combinations for which the required outcome can be achieved via
a ‘ratchet’ where the initial paired insecticide is swapped once for a new insecticide, with allele proportions at the time of the swap assumed to be 0.5%
resistance alleles and the maximum percentage of deflection alleles achieved whilst using the first insecticide. Results are calculated for 1% increments
Figure 2 continued on next page
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to spread and be maintained in the population, consistent with the relationships shown in Expres-
sion 1. For example, with the baseline parameter values, in a context in which insecticide-resistant
phenotypes have average per-cycle survival of 60% and deflected phenotypes have per-cycle survival
of 45%, an ESR introduced at a time when the prevalence of resistance and deflection alleles are
0.5% and 25% will become established, with the deflection allele spreading and deflected pheno-
types comprising more than 80% of the population 300 cycles after introduction (panel i), as shown
Figure 2 continued
in each survival value. Gridlines and diagonals are to aid visual location of results on the grid. The baseline parameters (panel i) are: 20% per
cyclesurvival of susceptible phenotypes; resistant deflected phenotypes have the same survival probability as non-resistant deflected phenotypes; 0.5%
initial prevalence of resistance alleles; and 25% initial prevalence of deflection alleles. Parameter values for panels (ii) to (iv) differ from the baseline
values as follows: panel (ii) 10% initial prevalence of deflection alleles; panel (iii) 2% initial prevalence of resistance alleles; and panel (iv) 60% per cycle
survival of susceptibles .
DOI: 10.7554/eLife.15416.006
The following figure supplement is available for figure 2:
Figure supplement 1. Effect of incomplete deflection on fitness combinations which support the spread and maintenance of deflection.
DOI: 10.7554/eLife.15416.007
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resistant phenotypes. The baseline parameters are: 20% per cycle survival of susceptible phenotypes; 0.5% initial
prevalence of resistance alleles; and 25% initial prevalence of deflection alleles.
DOI: 10.7554/eLife.15416.008
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by the light green square for 45% deflected survival with 60% resistant survival. However, if the initial
prevalence of deflection alleles is only 10%, then with the same per-cycle survival rates, deflection
alleles spread but are not sustained. Deflection can, however, be established by replacement of the
initial insecticide whilst deflection alleles are at their maximum prevalence (panel ii), as shown by the
dark green square for 45% deflected survival with 60% resistant survival.
From comparison of Figure 2 panel (i) and Figure 3, it can be seen that if a cost of resistance
affects resistant deflected phenotypes this serves to increase the range of deflection and resistance
fitness combinations for which deflection alleles can spread and be maintained.
Once the ESR is established, the impact of the ESR–insecticide combination treatment on
the transmission of Plasmodium will critically depend on the reduced vectorial capacity arising from
the exclusion of mosquitoes from treated properties. This will have two components. Reduced sur-
vival of deflected mosquitoes will reduce the population of adult mosquitoes, the probability of
infected mosquitoes surviving to give an infectious bite, and the number of bites that an infectious
mosquito will survive to give. In addition, anything which reduces the probability of transmission
from human host to a feeding mosquito, or from a feeding mosquito to a human host, will enhance
the reduction in transmission arising from deflection away from human dwellings. The level of trans-
mission of Plasmodium to or from mosquitoes that have transitioned to outdoor feeding is not yet
well-explored. In calculating the levels of infectious bites that correspond to given levels of deflected
mosquitoes in the population, we therefore represent all the possible sources of reduced transmis-
sion by deflected vectors as a range of possible parameter values for their probability per feed of
acquiring a Plasmodium infection, assuming probabilities of 4%, 2%, 1% and 0% (100%, 50%, 25% or
0% of the value assumed in the absence of deflection). From Figure 4, it can be seen that for a con-
text in which transmission is as efficient for deflected outdoor-feeding vectors as for vectors exposed
to no intervention, the initial reduction in infectious bites achieved when using an ESR (blue line with
squares) is comparable with, but not quite equal to, the reduction in infectious bites achievable using
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Figure 4. Effect of evolved spatial repellent on infectious bites from a vector population over time. The plots represent the infectious bites from the
vector population per unit of time as a proportion of that with no intervention, assuming use of insecticide with and without ESR and probabilities per
feed that ESR-deflected mosquitoes will become infected with Plasmodium of 4%, 2%, 1% or 0%. Plots otherwise use baseline parameter values.
Probability per feed that non-deflected mosquito acquires Plasmodium infection is assumed to be 4%. If the size of the human population is assumed
to be the same for all treatments and time periods, this equates to the entomological inoculation rate (EIR) as a percentage of the EIR with no
intervention.
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an insecticide alone (pink line with crosses). However, the reduction in bites achieved using the ESR
is maintained at a high level in the long term, while resistance rapidly eliminates the effectiveness of
the unpaired insecticide. When assuming some reduction in transmission for deflected
mosquitoes (lines with slash, circle and triangular markers), this trade-off between immediate and
long-term benefits is reduced, with the ESR offering an initial reduction in infectious bites very similar
to that achieved initially with insecticide alone, with the benefit again maintained or improved over
the long term.
Although the results summarized in Figures 1, 2 and 4 assume that resistant deflected pheno-
types have the same fitness as susceptible deflected phenotypes, consistent with a context in which
deflected phenotypes never enter a property treated with insecticide, and hence never experience
any fitness benefit from resistance, note that this is not a requirement for successful establishment of
an ESR, as illustrated in Figure 2—figure supplement 1.
Discussion
The use of DDT for indoor residual spray (IRS) programs proved an outstanding success in the history
of public health campaigns against malaria. Its withdrawal in the light of environmental concerns
reversed successes that approached elimination in some regions (Roberts, 2010; Curtis, 2002;
Roberts et al., 1997). By the time of its withdrawal,resistance to the toxic effects of DDT was
already widely observed, but there is empirical evidence to suggest that it may nonetheless have
maintained efficacy as a transmission-reduction agent through its action as an effective spatial
repellent (Roberts et al., 2000; Roberts and Alecrim, 1991). In part inspired by this, the deflection
of malaria-vector mosquitoes from indoor feeding at night to outdoor feeding is being actively inves-
tigated as a means to reduce malaria transmission (Achee et al., 2012; University of Notre Dame,
2016). Here, we show that combining a spatial repellent which initially repels only a small proportion
of a target vector population with indoor residual spraying of a high-toxicity insecticide can serve
both to create a highly effective spatial repellent and to protect the companion insecticide from the
rapid evolution of direct resistance to its toxic effects.
Our analysis provides the initial theoretical framework to spur empirical testing of this concept.
There is, however, already a body of empirical evidence consistent with our proposal that selection
can act to increase the efficacy of a repellent paired with a toxic insecticide. Our work predicts that,
given heritable behavioural traits in the exposed population, toxic substances encountered with suf-
ficient frequency and with sufficient volatility to be detectable at a distance would be observed to
show repellent action against exposed populations. In fact, many substances investigated because
of their repellent properties are also toxic on contact with target species. These include DEET, prob-
ably the most effective and well-known of the available repellents, as well as many of the naturally
repellent plant-based volatiles currently in use or under investigation for personal protection
(Xue et al., 2003; Licciardi et al., 2006). In fact, experiments that have combined repellents with
insecticides on bed nets have often found that the benefits arise from the additive or synergistic tox-
icity of the repellents (Pennetier et al., 2007; Faulde et al., 2010; N’guessan et al., 2008) to
an equivalent or greater degree than through their localized repellent effects. A comparison of the
behavioural and insecticidal effects of three public-health insecticides provides more direct evidence
of toxicity giving rise to repellency. The most toxic of the three, carbosulfan, also demonstrated high
spatial repellence in a population of susceptible mosquitoes but not in a resistant population
(Malima et al., 2009), an observation wholly consistent with our theoretical predictions.
The two elements defining the public-health benefits of an ESR used to deflect vectors away from
human dwellings are: (1) the proportion of the mosquito population affected by the ESR; and (2) the
reduction in infectious bites resulting from deflection. The former is dependent on the spread of the
deflection allele in the population. This is determined by the relative fitness of susceptible, resistant,
deflected and resistant-plus-deflected phenotypes, and by the initial prevalence of deflection and
resistance alleles when the combined ESR-insecticide intervention is introduced. Choices about how
the ESR and its associated insecticide are selected and deployed can influence or determine these
values. The potential for establishing an ESR is maximized by lower fitness values for susceptibles
and by higher fitness values for deflected phenotypes, indicating that control programs should tar-
get high coverage with high-efficacy insecticides to minimize the fitness of non-deflected suscepti-
bles. Critically, all treated properties should ideally be treated with both an insecticide and ESR,
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rather than with either alone, in order to maximize selection for deflection and to minimize selection
for physiological resistance. Minimising the entry of deflected phenotypes to insecticide-treated
properties avoids exposing deflected phenotypes to insecticide and hence reducing the average fit-
ness of deflected phenotypes relative to that of resistant phenotypes. Minimising the use of ESR on
properties without insecticide coverage, particularly during the establishment stage of an ESR,
avoids generating a fitness cost for deflected mosquitoes but not for non-deflected susceptible mos-
quitoes which can enter and feed. The use of a well-established ESR in a small number of properties
for which insecticide use is for some reason impossible may, however, comprise one of ESR’s poten-
tial benefits. A high initial proportion of deflection and a low proportion of resistance alleles in the
treated population also supports the spread of deflection alleles and the establishment of an ESR.
Although these values cannot be directly controlled, desirable values may be targeted through care-
ful choice of insecticide and ESR for each vector population. The candidate ESR can be chosen to
target an initial threshold level of deflection genotype in the population. The initial companion insec-
ticide can be chosen to target low initial levels of physiological resistance in the target population,
and could exploit high-toxicity insecticides that would normally show a very rapid loss to resistance,
serving both to maximize selection for deflected phenotypes and to give maximum immediate trans-
mission reduction benefits.
An ESR needs to be partnered with a suitable IRS insecticide, which should have low contact
repellence to maximize the mortality produced in non-deflected mosquitoes. Existing and new
chemical insecticides with low contact repellence and high toxicity, such as bendiocarb
(Evans, 1993), are therefore suitable as potential partner insecticides for an ESR program, poten-
tially transforming them from short-term solutions to sustainable tools. Furthermore fungal
biopesticides being developed for vector control potentially offer an ideal partnership with a spatial
repellency treatment, whether DDT or a novel chemical, as they appear to have no contact repel-
lency and have inherent resistance management benefits (Thomas and Read, 2007; Mnyone et al.,
2010). These novel biopesticides have previously been proposed as ‘evolution proof’ late-life-acting
insecticides (Read et al., 2009; Thomas and Read, 2007), offering respite from the treadmill of
insecticide loss to resistance. For late-life-acting insecticides, relatively low-virulence fungal strains
are ideal (Lynch et al., 2012), but much work on these organisms has focussed on generating high-
virulence strains (Fang et al., 2012). Given their low or absent contact repellence, such high-viru-
lence strains would provide ideal candidates for combination with an evolved spatial repellent, pro-
vided action can be taken before resistance becomes established in the target mosquito
populations.
Our focus is on repellence that prevents indoor-feeding malaria vectors from entering properties,
rather than on more localized repellence away from bed nets once vectors have entered properties.
The excito-repellent properties of some of the pyrethroid insecticides currently used on long-lasting
insecticide-treated nets (LLINs) reduce the mortality they generate by pushing vectors away before
they acquire a lethal dose (Grieco et al., 2007; Tananchai et al., 2012). Such reduced mortality
would diminish their likely efficacy as partner insecticides for ESRs. They could nonetheless enhance
the establishment of an ESR when deployed in combination with suitable IRS, by reducing the rela-
tive fitness both of non-deflected susceptible mosquitoes and of mosquitoes resistant to the IRS
insecticide. Such insecticides would also benefit from the resistance protection provided by an
established ESR. As one of the key public-health tools currently deployed, and one already showing
signs of succumbing to resistance (N’Guessan et al., 2007; Ochomo et al., 2014; Chandre et al.,
1999), protecting the efficacy of these compounds could be hugely beneficial. Further, in the search
for replacements for pyrethroids on bednets, alternative actives with low contact repellence could
make excellent partner insecticides for an ESR and again benefit from protection against a rapid loss
to resistance. If the partner insecticide is deployed via bednets then, as for IRS, the ESR can be
deployed separately, allowing it to be applied, refreshed, removed or replaced without requiring
any changes to the manufacture or maintenance of the LLINs.
The fitness cost of deflection away from indoor human hosts will vary according to vector species
and degree of anthropophilly. Clearly for species that are readily zoophagous, such as Anopheles
arabiensis, the fitness cost of diverting to a livestock host would be relatively low, provided that the
alternative host is present and accessible. For more anthropophilic species, such as Anopheles gam-
biae, the fitness cost of deflection must be higher, and may be expected to vary between local pop-
ulations depending on the feeding alternatives adopted. In assessing where ESRs offer high
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potential to contribute to public health campaigns, therefore, consideration should be given to the
detail of the species mix in the local population, and the availability of alternative hosts. Immigration
into the population will slow the spread of deflection, and so the size of a treated area is also a likely
determinant of success since a large enough treatment area can minimize immigration by effectively
including a whole breeding population within the treatment area. Equally, an isolated settlement
may provide a closed vector population over a relatively small treatment area.
The separation of repellence and toxicity provides additional benefits. The companion insecticide
can be changed whilst maintaining use of an established ESR. In contexts where an ESR can only be
established on a transient basis, for instance because resistance alleles are already relatively common
in the population when the ESR is introduced or because the population is subject to sustained
immigration of non-deflected phenotypes, the ESR may still be established using a ‘ratchet’
approach in which the insecticide used in combination with the ESR can be changed when deflection
phenotypes reach their peak, so that alleles for resistance to the new product will only offer a fitness
benefit if paired with the relatively small proportion of non-deflection genotypes remaining in the
population, allowing the deflection allele to spread. Where an ESR can become well established in
populations in which the fitness of resistant phenotypes is higher than that of deflected phenotypes,
unless the deflection allele reaches fixation, insecticide resistance will still spread eventually and
deflection will eventually disappear. However, replacement of the partner insecticide at a suitable
time will preserve the benefits of the established ESR, and the spread of resistance to the new part-
ner insecticide may be wholly suppressed. This might open public-health opportunities such as the
short-term use of a more expensive insecticide to generate ESR protection for the long-term use of
a cheaper alternative.
When the conditions for establishment of an ESR are met, then differential transmission for out-
door/early biting vs indoor biting is potentially very important for the outcome in terms of
reducing infectious bites. Because it is easiest to establish an ESR where deflection has little impact
on fitness, if the only mechanism by which deflection to outdoor biting has an effect on infectious
bites is through the incremental mortality associated with outdoor biting, then ESRs are most useful
in the circumstances where they are hardest to establish. However, many other factors may reduce
the probability per feed that a vector will acquire Plasmodium, or that, once infectious, it will trans-
mit the parasite to a human host.
There is empirical evidence of reduced Plasmodium infection in at least one vector population
which has transferred from indoor to outdoor biting (Ndiath et al., 2014). Ndiath et al.
(Ndiath et al., 2014) found no sporozooites in a population of insecticide-susceptible An. gambiae
pushed to outdoor feeding by the deployment of LLINs in Dielmo, whilst transmission continued at a
high level in an indoor-feeding resistant population (Ndiath et al., 2014). Whilst this specific exam-
ple cannot be unambiguously attributed to reduced transmission to/from outdoor feeding vectors
rather than, for example, to differential mortality rates, it is reasonable to consider other potential
causes of reduced outdoor transmission rates. These might include, for example, increased probabil-
ities of taking feeds from non-human hosts (Lefe`vre et al., 2009), differential availability of infec-
tious human hosts indoors and outdoors, reduced effectiveness of transmission outside normal
biting times (Gautret and Motard, 1999; Mideo et al., 2013; O’Donnell et al., 2011), and
increased active host response to early/outdoor feeding attempts. Deflection to outdoor biting
could therefore have dramatic effects on transmission that are independent of direct vector mortality
effects, and there is potential for easily established ESRs which are as effective as conventional insec-
ticides in reducing transmission, but on a much more sustainable basis.
There is still some controversy about the desirability of deflecting mosquitoes away from indoor
biting and the well-established control methods which exploit this behaviour. The spatial repellent
concept (whether evolved or conventional) is predicated on the idea that forcing vectors and Plas-
modium into behavioural options that offer them lower fitness outcomes will inherently provide a
new and potentially sustainable means of reducing transmission (Achee et al., 2012). However, out-
door biting is commonly viewed as a route to increased vector activity in a context where personal
protection and anti-vector measures are hard to action (Bradley et al., 2012). In some contexts, for
some compounds, the ESR concept may help to generate and sustain repellents that are able to pro-
tect against outdoor biting in the vicinity of treated properties, but in some locations it may none-
theless be the case that producing a move to outdoor biting simply does not generate overall
transmission reductions equivalent to those achieved by control measures applied directly to indoor-
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feeding vectors. Transmission reductions may also change over time; for example, if outdoor biting
initially generates low transmission because the accessible outdoor human hosts are all adults
who have partial immunity, successful protection of children would eventually generate increasing
numbers of susceptible adults who will in turn be exposed to outdoor feeding vectors, eliminating
this benefit. It might also be argued that, whether beneficial or detrimental, outdoor biting will inevi-
tably evolve as a behavioural resistance mechanism, and therefore that the use of an ESR is irrele-
vant. However, we would argue that ESRs offer benefits even in contexts where a transition to
outdoor biting is ultimately found to be detrimental. For vectors that preferentially feed indoors,
there is an expected fitness cost to a switch to outdoor feeding. Selection should therefore favour
the use of a ‘cue’ to determine host choice, allowing the fitness benefits of indoor feeding to be
enjoyed wherever safe, whilst avoiding the costs of entering insecticide-treated properties. Where
ESRs are used in such contexts, either they will have no effect at all (i.e. they will do no harm nor
good) or at least part of the vector population selected to respond to a ‘cue’ will be ‘cued’ by the
ESR. This means that, should outdoor feeding prove undesirable at some point, the transition to out-
door feeding will be at least partly reversible since, unlike direct responses to an insecticide or to
entering buildings, the response to an ESR will cease to affect vector behaviour if the ESR is
withdrawn.
As well as being reversible in its effects, unlike many resistance-management strategies, ESR
does not require the withdrawal or reduction of existing control measures in order to be effective.
All novel interventions carry potential for harm, however, if they divert limited resources away from
more effective control measures. In order to minimize potential harm as well as maximising potential
benefits therefore, candidate ESRs should be cheap to obtain, and cheap and easy to deploy in the
field. Unlike IRS, there is no imperative to cover interior surfaces with an ESR as they are intended to
act at a distance, deployment as a single-spot event should therefore be possible. If this is formatted
as a simple physical item, for example a small disc of impregnated paper, it can be deployed without
the need for any special equipment. For ease of acceptance, candidate ESRs should have no detect-
able unpleasant odour for humans. To minimize unintended fitness costs for deflection, candidate
substances should not be common in the natural environment of the target vector population. Any
carrying material used for ESR distribution should be cheap, readily available, not amenable to other
practical use, resistant to degradation and inedible for animals with indoor access.
The evolution of behavioural change in response to pesticides is also a recognized issue for agri-
cultural insecticide use (Castillo-Chavez et al., 1988; Kennedy et al., 1987; Jongsma et al., 2010)
and it is interesting to note that in the early 1980s Gould (1984) suggested that some insect popula-
tions might be expected to evolve behavioural avoidance of agricultural insecticides which were not
originally repellent to them, and that in many situations, physiological resistance would evolve more
slowly to insecticide formulations with high repellency than to non-repellent formulations. Whereas
use in agriculture is commonly highly detrimental to the sustained utility of public-health tools, the
parallel potential for ESRs in human health and agriculture may in some contexts allow agricultural
use to enhance their public health role. In areas where vectors rest in insecticide-treated crops, using
a vector-control spatial repellent on crops in combination with agricultural insecticides may serve to
enhance selection for deflection alleles without generating any selection pressure for physiological
resistance to public health insecticides (whilst incidentally providing some resistance-management
for agricultural pesticides). This might also be a means to apply selection to nectar-feeding males, or
to enhance selection for deflection in contexts where there is some existing resistance to all available
public health insecticides but not to the agricultural insecticides being used locally.
Work carried out since the widescale use of DDT was terminated has clarified the role of spatial
repellence in its contribution to malaria control (Roberts et al., 2000). Given its highly effective spa-
tial repellence combined with high toxicity and the ubiquity of its use, it is perhaps interesting to
consider whether DDT was always an effective repellent, or whether it actually provides the first
empirical example of the ESR concept in action?
Our models suggest that there is clear potential to use evolution to create better control through
evolved spatial repellence, and we hope to stimulate empirical work to test both our assumptions
and the application of this novel approach. More generally, we demonstrate the importance of tak-
ing into account and modeling the evolutionary implications of different methods of insect control
and medical interventions more broadly. We provide an example in which the inevitable evolution of
the target insects can be used to improve rather than to reduce the effectiveness of the intervention.
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When evaluating a new intervention detailed mathematical modeling of the evolutionary outcomes
alongside the more commonly considered epidemiological outcomes has considerable potential to
improve infectious disease control. We recommend bringing together theoretical and empirical
work to explore fully the potential of the ESR concept.
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Appendix 1
Definition of the PM model
Appendix 1—table 1. Variable and parameter definitions for the population genetics model.
Variable and parameter labels
Label Description Units
t
Index of model time periods
length of one time period equivalent to duration of one gonotrophic cycle
Time
h
Index of phenotypes
1= susceptible non-deflected
2 = resistant non-deflected
3 = resistant and deflected
4 = susceptible deflected
g
Index of genotypes
1=rrdd, 2=rRdd, 3=RRdd, 4=rrDd, 5=rRDd,
6=RRDd, 7=rrDD, 8=rRDD, 9=RRDD
Dw;t
The proportion of male gametes with allele pair w in time period t.
Pairs are: 1=rd, 2=rD, 3=Rd, 4=RD
Proportion of male ga-
metes
Tt
Infectious bites from population in period t as a proportion of baseline (pre-
treatment) infectious bites per period
Proportion of baseline
bites/time
It
Females giving infectious bites in period t as a proportion of females in
baseline population
Proportion of baseline
population
Mh;t
Females of phenotype h which are infectious with Plasmodium in period t as
a proportion of baseline population
Proportion of baseline
population
c0
Baseline probability that an infectious female in the no-intervention baseline
population will give an infectious bite when feeding
Probability
ch
Probability that an infectious female of phenotype h will give an infectious
bite when feeding
Probability
mh;t
Females newly infected with Plasmodium in period t as a proportion of the
baseline population
Proportion of baseline
population
b0
Baseline average probability susceptible individuals survive one model time
period (in the absence of any intervention)
Probability
bh
Average probability that individuals with phenotype h will survive one time
period in an environment including a given intervention
Probability
g
Number of model time periods between start of Plasmodium infection in
mosquito, and point from which infection has matured and mosquito can
give infectious bites
Model time periods
b0
Probability that an uninfected mosquito in a baseline population subject to
no interventions will acquire a Plasmodium infection during a single model
time-period
Probability
bh
Probability that an uninfected mosquito with phenotype h will acquire a
Plasmodium infection during a single time-period
Probability
Uh;t
Females with phenotype h which are not infected with Plasmodium at start
of time period t, as a proportion of the baseline population
Proportion of baseline
population
Jh;t
New females of phenotype h in period t, as a proportion of the baseline
population
Proportion of baseline
population
Bg;t Proportion of new adults in time period t with genotype g
Proportion of new
adults
t1;t New (female) adults in period t as proportion of baseline population
Proportion of baseline
population
t2;t
Adults surviving from preceding period to start of period t as proportion of
baseline population
Proportion of baseline
ppopulation
t3;t
New (female) adults in period t as a proportion of total (female) population
in period t
Proportion of current
population
Appendix 1—table 1 continued on next page
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Appendix 1—table 1 continued
Variable and parameter labels
Label Description Units
t4;t
Adults surviving from preceding period to start of period t as proportion of
population in period t
Proportion of current
population
t5;t Population in period t as proportion of baseline population
Proportion of baseline
population
Sg Probability a female with genotype g will survive one model time period Probability
Eg;t Proportion of all eggs laid in time period t which have genotype g
Proportion of eggs laid
in period
Kg;t
Proportion of adult females surviving at start of time period t which have
genotype g
Proportion of adult fe-
males
$ Number of time periods between egg-laying and emergence of new adults Model time periods
Wg;t
The proportion of all females (including new adult females) which have
genotype g at start of time period t
Proportion of adult fe-
males
 t
Proportion of the population alive at start of time period t   1 which survive
to start of time period t
Proportion of popula-
tion
g;t
Number of eggs with genotype g laid in period t, relative to a normalized
number of eggs assumed per mosquito per successful lay
Relative number of
eggs
dt
Total number of eggs laid in period t, relative to a normalized number of
eggs assumed per mosquito per successful lay
Relative number of
eggs
Zg;j;t
The proportion of eggs produced by females which are new adults in time
period t and have genotype j, which are genotype g
Proportion of eggs
Ag;t
Average number of eggs laid during time period t by females with
genotype g alive at start of time period t
Normalized number of
eggs
L Normalized number of eggs assumed per mosquito per successful lay Eggs/mosquito/lay
Xt
Newly mated females in time period t as a proportion of the baseline
population
Proportion of
baseline population
G1;t
Proportion of alleles at the resistance locus which are resistance alleles in
model time period t
Proportion of alleles
G2;t
Proportion of alleles at the deflection locus which are deflection alleles in
model time period t
Proportion of alleles
P1;t Proportion of population with resistant phenotypes in model time period t
Proportion of
current population
P2;t Proportion of population with deflected phenotypes in model time period t
Proportion of
current population
P3;t
Proportion of population with susceptible non-deflected phenotypes in
model time period t
Proportion of current
population
Vy;t
Proportion of population with genotype y in model time period t
genotypes; 1=rr, 2=rR or RR, 3=dd, 4=dD or DD
Proportion of current
population
DOI: 10.7554/eLife.15416.010
The model tracks the population of adult females and assumes a ‘baseline population’ of
stable size (new adult recruitment rate is constant and equal to adult mortality rate) in the
absence of any insecticide or ESR interventions. It is assumed that larval habitats are over-
subscribed, and variations in the adult population do not materially change the number of
juveniles reaching maturity and joining the adult population in each time period. Females are
assumed to mate once, as newly emerged adults, mating with males having the same
genotype proportions as newly emerged adult females.
t represents the index of model time periods, with t ¼ 0 representing the periods prior to
application of an intervention when the population is the baseline population.
Sg, the probability that a female with genotype g will survive one time period, is the primary
input value driving the spread of different alleles in the popgen model. Each genotype is
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associated with one of the four possible phenotypes. Each phenotype has an associated per
period survival probability.
Infectious bites from population in period t as a proportion of baseline infectious bites,
Tt ¼
It
I0
.
Females giving infectious bites in period t as a proportion of females in the baseline
population, It ¼
P4
h¼1
Mh;tch.
The females of genotype h that are newly infected with Plasmodium in period t, as a
proportion of the baseline population, mh;t, is calculated as mh;0 ¼ Uh;0b0b0 and mh;t ¼ Uh;tbhbh
with t>0.
Mh;t females of phenotype h that are infectious with Plasmodium in period t as a proportion
of baseline population, calculated for the baseline population as the total proportion of
newly infected females in each period, for all periods up to g periods (number of periods
between Plasmodium infection and infectiousness) ago, multiplied by the probability of
surviving to g periods ago, multiplied by the probability of surviving g periods,
Mh;0 ¼
mh;0
1  b0
b0
g.
After baseline period, Mh;t is calculated for each phenotype as surviving infectious females
from the previous period, plus survivors from newly infected females with that phenotype
from g periods ago. Mh;t ¼ Mh; t 1ð Þbh þ mh; t min t;gð Þð Þbh
g t>0
Females with phenotype h that are not infected with Plasmodium at start of time period t, as
a proportion of the baseline population.
For the baseline population, Uh;0, the non-infected females at the start of each time period
are calculated for each phenotype as the sum of the surviving, uninfected new females from
all past time periods, assuming a constant value for new females of each phenotype in each
period, Uh;0 ¼
Jh;0
1  b0ð1  b0Þ
. Post-introduction of the intervention, the non-infected females
for each genotype at the start of each time period are calculated as the surviving non-
infected females from the previous period plus new females of that genotype, giving Uh;t ¼
Uh;t 1bhð1  bhÞ þ Jh;t with t>0.
Jh;t, new females of phenotype h in period t, expressed as a proportion of the baseline
population, is calculated as the proportion of the new adults in period t that have genotypes
corresponding to phenotype h.
New susceptible females in time period t as a proportion of the baseline population,
J1;t ¼ B1;tt1;t:
New deflected females in time period t as a proportion of the baseline population,
J2;t ¼ B4;t þB7;t
  
t1;t:
New resistant females in time period t as a proportion of the baseline population,
J3;t ¼ B2;t þB3;t
  
t1;t:
New deflected-resistant females in time period t as a proportion of the baseline population,
Lynch and Boots. eLife 2016;5:e15416. DOI: 10.7554/eLife.15416 21 of 31
Research article Epidemiology and Global Health Genomics and Evolutionary Biology
J4;t ¼ B5;t þB6;t þB8;t þB9;t
  
t1;t:
For this analysis, it is assumed that larval habitats are over-subscribed and that the number of
new adults recruited to the population in each time period remains constant with and
without interventions. In all time periods therefore, the number of new (female) adults joining
the population is the same as for the baseline population. Since the baseline population is
assumed to be constant, the proportion of the population comprising new adults in each
time period in the baseline population can be calculated as t1;t ¼ 1  b0.
t2;t, adult females surviving from the preceding period to the start of period t as a proportion
of the baseline population, is calculated as t2;0 ¼ 1  t1;0 and
t2;t ¼
P9
g¼1
t1;t 1Bg;t 1 þ t2;t 1Kg;t 1
  
Sg with t > 0.
New (female) adults in period t as a proportion of the total of population in period t,
t3;t ¼
t1;t
t1;t þ t2;t
:
Adult females surviving from the preceding period to the start of period t as a proportion of
the population in period t, t4;t ¼
t2;t
t1;t þ t2;t
:
Population of adult females in period t as a proportion of the baseline
population, t5;t ¼ t1;t þ t2;t.
The proportion of new adults in each cycle that have genotype g in the baseline population,
Bg;0 is calculated based on specified initial allele proportions, assuming Hardy-Weinberg
equilibrium (independently for each locus).
The proportion of new adults in time period t (with t > 0) that have genotype g is calculated
as the proportion of eggs with that genotype from $ periods ago, where $ represents the
number of model time periods required for development from egg to new adults. For early
time periods, before t > $, the baseline egg genotype proportions are used (t ¼ 0), giving
Bg;t ¼ Eg;t min t;$ð Þ.
The proportion of surviving adult females at start of time period t that have genotype g, Kg;t,
for the baseline population is the same as the proportion of eggs with that genotype, giving
Kg;0 ¼ Bg;0, since in the absence of an intervention there is assumed to be no difference in
survival or fecundity between the phenotypes associated with each genotype. Note that for
simplicity, this assumption is applied to the baseline population even when a cost of
resistance is considered once an intervention is introduced. Following introduction of an
intervention, the proportion of surviving adult females at start of time period t that have
genotype g is calculated as the proportion of females with genotype g that survive from the
previous period, divided by the total proportion surviving, with all genotypes, giving
Kg;t ¼
Wg;t 1Sg
 t
t> 0.
Wg;t, the proportion of females with genotype g at start of time period t is calculated as the
sum of new adults and surviving adults with that genotype at that time,
Wg;t ¼ Bg;tt3;t þ Kg;tt4;t:
 t, the proportion of the population alive at start of time period t   1 that survive to start of
time period t is calculated as the sum of the proportions with each genotype alive at start of
time period t   1 multiplied by the one-period survival probability associated with that
genotype  t ¼
P9
i¼1
ðWi;t 1SiÞ.
The model assumes that females mate once, as new adults, with newly emerged adult males.
The normalized number of eggs with genotype g laid in period t, g;t, is therefore calculated
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as the total for all previous periods of the proportion of eggs of genotype g resulting from
mating with new males in that period, for females of each genotype, multiplied by the
probability for females of that genotype of surviving to period t:
t g;t ¼
Pt
i¼1
P9
j¼1
ðBj;iZg;j;iAj;iSj
t iÞt1;i
8>>:
9>>;.
The proportion of the eggs laid in time period t that have genotype g is calculated as
Eg;t ¼
g;t
dt
:
The total (normalized) number of eggs laid in period t is calculated as dt ¼
P9
g¼1
g:t :
Some combinations of maternal and offspring genotypes are not possible, so the proportion
of eggs of genotype g produced by females with genotype j that are new adults in time
period t, Zg;j;t ,is zero for all time periods for some genotypes.
Z1;i;t ¼ 0 i¼ 3;6;7;8;9f g
Z2;i;t ¼ 0 i¼ 7;8;9f g
Z3;i;t ¼ 0 i¼ 1;7;8;9f g
Z4;i;t ¼ 0 i¼ 3;6;9f g
Z6;i;t ¼ 0 i¼ 1;4;7f g
Z7;i;t ¼ 0 i¼ 1;2;3;7;9f g
Z8;i;t ¼ 0 i¼ 1;2;3f g
Z9;i;t ¼ 0 i¼ 1;2;3;4;7f g
For other combinations values are calculated as follows:
Z1;1;t ¼ D1;t
% eggs which are genotype rrdd in time period t
for new females with genotype rrdd
Z1;2;t ¼ 0:5D1;t
% eggs which are genotype rrdd in time period t
for new females with genotype rRdd
Z1;4;t ¼ 0:5D1;t
% eggs which are genotype rrdd in time period t
for new females with genotype rrdD
Z1;5;t ¼ 0:25D1;t
% eggs which are genotype rrdd in time period t
for new females with genotype rRdD
Z2;1;t ¼ D3;t
% eggs which are genotype rRdd in time period
t for new females with genotype rrdd
Z2;2;t ¼ 0:5 D1;t þ D3;t
   % eggs which are genotype rRdd in time period
t for new females with genotype rRdd
Z2;3;t ¼ D1;t
% eggs which are genotype rRdd in time period
t for new females with genotype RRdd
Z2;4;t ¼ 0:5D3;t
% eggs which are genotype rRdd in time period
t for new females with genotype rrdD
Z2;5;t ¼ 0:25 D1;t þ D3;t
   % eggs which are genotype rRdd in time period
t for new females with genotype rRdD
Z2;6;t ¼ 0:5D1;t
% eggs which are genotype rRdd in time period
t for new females with genotype RRdD
Z3;2;t ¼ 0:5D3;t
% eggs which are genotype RRdd in time period
t for new females with genotype rRdd
Z3;3;t ¼ D3;t
% eggs which are genotype RRdd in time period
t for new females with genotype RRdd
Z3;5;t ¼ 0:25D3;t
% eggs which are genotype RRdd in time period
t for new females with genotype rRdD
Z3;6;t ¼ 0:5D3;t
% eggs which are genotype RRdd in time period
t for new females with genotype RRdD
continued on next page
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Z4;1;t ¼ D2;t
% eggs which are genotype rrdD in time period
t for new females with genotype rrdd
Z4;2;t ¼ 0:5D2;t
% eggs which are genotype rrdD in time period
t for new females with genotype rRdd
Z4;4;t ¼ 0:5 D1;t þ D2;t
   % eggs which are genotype rrdD in time period
t for new females with genotype rrdD
Z4;5;t ¼ 0:25 D1;t þ D2;t
   % eggs which are genotype rrdD in time period
t for new females with genotype rRdD
Z4;7;t ¼ D1;t
% eggs which are genotype rrdD in time period
t for new females with genotype rrDD
Z4;8;t ¼ 0:5D1;t
% eggs which are genotype rrdD in time period
t for new females with genotype rRDD
Z5;1;t ¼ D4;t
% eggs which are genotype rRdD in time period
t for new females with genotype rrdd
Z5;2;t ¼ 0:5 D2;t þ D4;t
   % eggs which are genotype rRdD in time period
t for new females with genotype rRdd
Z5;3;t ¼ D2;t
% eggs which are genotype rRdD in time period
t for new females with genotype RRdd
Z5;4;t ¼ 0:5 D3;t þ D4;t
   % eggs which are genotype rRdD in time period
t for new females with genotype rrdD
Z5;5;t ¼ 0:25 D1;t þ D2;t þ D3;t þ D4;t
   % eggs which are genotype rRdD in time period
t for new females with genotype rRdD
Z5;6;t ¼ 0:5 D1;t þ D2;t
   % eggs which are genotype rRdD in time period
t for new females with genotype RRdD
Z5;7;t ¼ D3;t
% eggs which are genotype rRdD in time period
t for new females with genotype rrDD
Z5;8;t ¼ 0:5 D1;t þ D3;t
   % eggs which are genotype rRdD in time period
t for new females with genotype rRDD
Z5;9;t ¼ D1;t
% eggs which are genotype rRdD in time period
t for new females with genotype RRDD
Z6;2;t ¼ 0:5D4;t
% eggs which are genotype RRdD in time
period t for new females with genotype rRdd
Z6;3;t ¼ D4;t
% eggs which are genotype RRdD in time
period t for new females with genotype RRdd
Z6;5;t ¼ 0:25 D3;t þ D4;t
   % eggs which are genotype RRdD in time
period t for new females with genotype rRdD
Z6;6;t ¼ 0:5 D3;t þ D4;t
   % eggs which are genotype RRdD in time
period t for new females with genotype RRdD
Z6;8;t ¼ 0:5D3;t
% eggs which are genotype RRdD in time
period t for new females with genotype rRDD
Z6;9;t ¼ D3;t
% eggs which are genotype RRdD in time
period t for new females with genotype RRDD
Z7;4;t ¼ 0:5D2;t
% eggs which are genotype rrDD in time
period t for new females with genotype rrdD
Z7;5;t ¼ 0:25D2;t
% eggs which are genotype rrDD in time
period t for new females with genotype rRdD
Z7;7;t ¼ D2;t
% eggs which are genotype rrDD in time
period t for new females with genotype rrDD
Z7;8;t ¼ 0:5D2;t
% eggs which are genotype rrDD in time
period t for new females with genotype rRDD
Z8;4;t ¼ 0:5D4;t
% eggs which are genotype rRDD in time
period t for new females with genotype rrDD
Z8;5;t ¼ 0:25 D2;t þ D4;t
   % eggs which are genotype rRDD in time
period t for new females with genotype rRdD
continued on next page
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Z8;6;t ¼ 0:5D2;t
% eggs which are genotype rRDD in time
period t for new females with genotype RRdD
Z8;7;t ¼ D4;t
% eggs which are genotype rRDD in time
period t for new females with genotype rrDD
Z8;8;t ¼ 0:5 D2;t þ D4;t
   % eggs which are genotype rRDD in time
period t for new females with genotype rRDD
Z8;9;t ¼ D2;t
% eggs which are genotype rRDD in time
period t for new females with genotype RRDD
Z9;5;t ¼ 0:25D4;t
% eggs which are genotype RRDD in time
period t for new females with genotype rRdD
Z9;6;t ¼ 0:5D4;t
% eggs which are genotype RRDD in time
period t for new females with genotype RRdD
Z9;8;t ¼ 0:5D4;t
% eggs which are genotype RRDD in time
period t for new females with genotype rRDD
Z9;9;t ¼ D4;t
% eggs which are genotype RRDD in time
period t for new females with genotype RRDD
The average number of eggs laid during time period t by females with genotype g that are
alive at the start of time period t, Ag;t, is calculated as the normalized number of eggs per
mosquito per lay, multiplied by the probability that females of genotype g will survive one
time period. For the baseline population, this gives Ag;0 ¼ b0L, and for the population post
introduction of an intervention, Ag;t ¼ SgL t>0 .
The model is interested in comparative and proportionate rather than absolute values for
egg production, for convenience therefore, we use a normalized value for the number of
eggs assumed per mosquito per successful lay, represented by L.
Xt represents the newly mated females in time period t as % baseline population. For the
baseline population, the genotype proportions in females and their eggs is assumed to be
constant over time. Females surviving from the baseline population will therefore contribute
eggs to subsequent periods with the same genotype proportions in the eggs for each
maternal genotype, irrespective of age. For this purpose, therefore, as all females will have
the same characteristics as newly mated females, we have X0 ¼ 1. Thereafter Xt ¼ t1;t, with
t>0.
Mating males in time period t are assumed to have the genotype proportions of newly
emerged adults in period t. With allele pairs indexed as 1=rd, 2=rD, 3=Rd, 4=RD, the
proportion of male gametes with allele pair w in time period t, Dw;t, is therefore calculated as:
D1;t ¼ B1;t þ 0:5 B2;t þB4;t
  
þ 0:25B5;t
D2;t ¼ B7;t þ 0:5 B4;t þB8;t
  
þ 0:25B5;t
D3;t ¼ B3;t þ 0:5 B2;t þB6;t
  
þ 0:25B5;t
D4;t ¼ B9;t þ 0:5 B8;t þB6;t
  
þ 0:25B5;t
The proportion of alleles at the resistance locus in the population at time period t that are
resistance alleles, G1;t, is calculated as G1;t ¼ W3;t þW6;t þW9;t þ 0:5 W2;t þW5;t þW8;t
  
.
The proportion of alleles at the deflection locus in the population at time period t that are
deflection alleles, G2;t, is calculated as G2;t ¼ 0:5 W4;t þW5;t þW6;t
  
þW7;t þW8;t þW9;t.
The proportion of the adult female population in time period t that have resistant (non-
deflected) phenotypes, P1;t, is the sum of those with genotypes rRdd or RRdd,
P1;t ¼ W2;t þW3;t.
The proportion of the adult female population in time period t that have deflected
phenotypes, P2;t, is the sum of those with genotypes having Dd or DD in combination with
any allele combination at the resistance locus, P2;t ¼
P9
i¼4
Wi;t.
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The proportion of the adult female population in time period t that have susceptible, non-
deflected phenotypes, P3;t, is equal to the proportion with rrdd
genotypes: P3;t ¼ 1  P1;t   P2;t.
The proportion of the adult female population in time period t that have two susceptible
alleles (rr) at the resistance locus, V1;t, is calculated as V1;t ¼ W1;t þW4;t þW7;t.
The proportion of the adult female population in time period t that have at least one
resistance allele (rR, RR) at the resistance locus, V2;t, is calculated as
V2;t ¼ W2;t þW3;t þW5;t þW6;t þW8;t þW9;t.
The proportion of the adult female population in time period t that have two non-deflection
alleles (dd) at the deflection locus, V3;t, is calculated as V3;t ¼ W1;t þW2;t þW3;t.
The proportion of the adult female population in time period t that have at least one
deflection allele (rD, DD) at the resistance locus, V4;t, is calculated as V4;t ¼
P9
i¼4
Wi;t.
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Appendix 2
Derivation of Equations 1 and 2 and Expressions 1 and 2
Because the fitness of the individuals carrying deflection and non-deflection alleles depends on
whether they are also carrying resistance alleles, and because resistance alleles may originate
from the same parent as the relevant deflection allele or from the paired zygote, we consider
the average fitness of the phenotypes into which deflection and non-deflection alleles will be
inherited, based on the proportions of each possible allele pair in the population of zygotes,
assuming the same proportions in gametes of mating males and newly emerged females.
Consider the allele pairs in gametes in the mating adult population:
dr½  ¼ proportion of deflection locus alleles which are non-deflection alleles paired with
non-resistance alleles in gametes
dR½  ¼ proportion of deflection locus alleles which are non-deflection alleles paired with
resistance alleles in gametes
Dr½  ¼ proportion of deflection locus alleles which are deflection alleles paired with
non-resistance alleles in gametes
DR½  ¼ proportion of deflection locus alleles which are deflection alleles paired with
resistance alleles in gametes
d ½  ¼ proportion of deflection locus alleles in gametes which are non-deflection alleles
D ½  ¼ proportion of deflection locus alleles in gametes which are deflection alleles
 r½  ¼ proportion of deflection locus alleles which are paired with susceptible alleles in gametes
 R½  ¼ proportion of deflection locus alleles which are paired with resistance alleles in gametes
d ½ þ D ½  ¼  r½ þ  R½  ¼ 1
Let S½ d represent the proportion of non-deflection alleles inherited into offspring with
genotypes corresponding to susceptible, non-deflected phenotypes:
S½ d¼
dr½ 2
d ½ 
:
Let R½ d represent the proportion of non-deflection alleles inherited into offspring with
genotypes corresponding to resistant, non-deflected phenotypes:
R½ d¼
dr½  dR½ þ dR½  dr½ þ dR½  dR½ 
d ½ 
¼
d ½  dR½ þ dR½  dr½ 
d ½ 
¼ dR½  þ
dR½  dr½ 
d ½ 
:
Let DR½ d represent the proportion of non-deflection alleles inherited into offspring with
genotypes corresponding to resistant, deflected phenotypes:
DR½ d¼
dr½  DR½  þ dR½  Dr½  þ dR½  DR½ 
d ½ 
¼
d ½  DR½  þ dR½  Dr½ 
d ½ 
¼ DR½  þ
dR½  Dr½ 
d ½ 
:
Let D½ d represent the proportion of non-deflection alleles inherited into offspring with
genotypes corresponding to non-resistant, deflected phenotypes:
D½ d¼
dr½  Dr½ 
d ½ 
:
Let FS represent the fitness of susceptible, non-deflected phenotypes.
Let FR represent the fitness of resistant, non-deflected phenotypes.
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Let FRD represent the fitness of resistant, deflected phenotypes.
Let FD represent the fitness of non-resistant, deflected phenotypes.
Let FD represent the average fitness of offspring into which deflection alleles are inherited.
Let DR½ D represent the proportion of deflection alleles inherited into offspring with genotypes
corresponding to resistant, deflected phenotypes:
DR½ D ¼
Dr½  dR½  þ Dr½  DR½  þ DR½  DR½  þ DR½  Dr½  þ DR½  dR½  þ DR½  dr½ 
D ½ 
¼  R½  þ
DR½   r½ 
D ½ 
Let D½ D represent the proportion of deflection alleles inherited into offspring with genotypes
corresponding to non-resistant, deflected phenotypes:
D½ D ¼
Dr½  dr½  þ Dr½  Dr½ 
D ½ 
¼
Dr½   r½ 
D ½ 
FD ¼ DR½ DFRDþ D½ DFD
¼  R½  þ
DR½   r½ 
D ½ 
 
FRDþ
Dr½   r½ 
D ½ 
FD
¼ FSþ
Dr½   R½ þ DR½ 
D ½ 
FRD FSð Þþ
Dr½   r½ 
D ½ 
FD FSð Þ
This is Equation 1.
Let Fd represent the average fitness of offspring into which non-deflection alleles are
inherited:
Fd ¼ ½SdFSþ ½RdFRþ RD½ dFRDþ D½ dFD
Fd ¼
dr½ 2
d ½ 
FSþ dR½  þ
dR½  dr½ 
d ½ 
 
FRþ DR½ þ
dR½  Dr½ 
d ½ 
 
FRDþ
dr½  Dr½ 
d ½ 
FD
Fd ¼ FSþ dR½  þ
dR½  dr½ 
d ½ 
 
FR FSð Þþ
dr½  Dr½ 
d ½ 
FD FSð Þþ DR½ þ
dR½  Dr½ 
d ½ 
 
FRD FSð Þ
This is Equation 2.
Deflection alleles will spread when the average fitness of offspring into which deflection alleles
are inherited is higher than that of offspring into which non-deflection alleles are inherited:
FD >Fd $ FSþ
Dr½   R½ þ DR½ 
D ½ 
FRD FSð Þþ
Dr½   r½ 
D ½ 
FD FSð Þ
>FSþ dR½ þ
dR½  dr½ 
d ½ 
 
FR FSð Þþ DR½  þ
dR½  Dr½ 
d ½ 
 
FRD FSð Þþ
dr½  Dr½ 
d ½ 
FD FSð Þ
This can be rearranged as follows to give Expression 1.
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FD > Fd $
Dr½   R½  þ DR½ 
D ½ 
FRD FSð Þþ
Dr½   r½ 
D ½ 
FD FSð Þ
> dR½ þ
dR½  dr½ 
d ½ 
 
FR FSð Þþ DR½ þ
dR½  Dr½ 
d ½ 
 
FRD FSð Þþ
dr½  Dr½ 
d ½ 
FD FSð Þ
FD > Fd $
Dr½   R½  þ DR½ 
D ½ 
FRD FDð Þþ
Dr½   r½ þ Dr½   R½ þ DR½ 
D ½ 
FD FSð Þ
> dR½ þ
dR½  dr½ 
d ½ 
 
FR FSð Þþ DR½ þ
dR½  Dr½ 
d ½ 
 
FRD FDð Þ
þ
dr½  Dr½ 
d ½ 
þ DR½  þ
dR½  Dr½ 
d ½ 
 
FD FSð Þ
FD > Fd $
Dr½   R½  þ DR½ 
D ½ 
FRD FDð Þþ FD FSð Þ
> dR½ þ
dR½  dr½ 
d ½ 
 
FR FSð Þþ D ½  FD FSð Þþ DR½ þ
Dr½  dR½ 
d ½ 
 
FRD FDð Þ
FD > Fd $ FD FSð Þ
> dR½ þ
dR½  dr½ 
d ½ 
 
FR FSð Þþ D ½  FD FSð Þþ DR½ þ
Dr½  dR½ 
d ½ 
 
Dr½   R½  þ DR½ 
D ½ 
 
FRD FDð Þ
FD >Fd $ FD FSð Þ>
D ½  FD FSð Þþ dR½  1þ
dr½ 
d ½ 
 
FR FSð Þ
þ DR½  1 
1
D ½ 
 
þ Dr½ 
dR½ 
d ½ 
 
 R½ 
D ½ 
  
FRD FDð Þ
FD >Fd $ FD FSð Þ> D ½ þ dR½ þ
dR½  dr½ 
d ½ 
 
FD FSð Þþ dR½  1þ
dr½ 
d ½ 
 
FR FDð Þ
þ DR½  1 
1
D ½ 
 
þ Dr½ 
dR½ 
d ½ 
 
 R½ 
D ½ 
  
FRD FDð Þ
dR½ þ
dR½  dr½ 
d ½ 
¼ dR½  þ
dR½  dr½ 
dR½ þ dr½ 
¼
dR½  dR½  þ dr½ ð Þþ dR½  dr½ 
dR½ þ dr½ 
¼
dR½ 2þ dR½  dr½  þ dR½  dr½ 
dR½ þ dr½ 
¼
dR½ þ dr½ ð Þ2  dr½ 2
dR½  þ dr½ 
¼ d ½  
dr½ 2
d ½ 
\FD >Fd $ FD FSð Þ> D ½ þ d ½  
dr½ 2
d ½ 
 !
FD FSð Þþ dR½  1þ
dr½ 
d ½ 
 
FR FDð Þ
þ DR½  1 
1
D ½ 
 
þ Dr½ 
dR½ 
d ½ 
 
 R½ 
D ½ 
  
FRD FDð Þ
FD >Fd $ FD FSð Þ> 1 
dr½ 2
d ½ 
 !
FD FSð Þþ dR½  1þ
dr½ 
d ½ 
 
FR FDð Þ
þ DR½  1 
1
D ½ 
 
þ Dr½ 
dR½ 
d ½ 
 
 R½ 
D ½ 
  
FRD FDð Þ
FD >Fd $
dr½ 2
d ½ 
FD FSð Þ> dR½  1þ
dr½ 
d ½ 
 
FR FDð Þ
þ DR½  1 
1
D ½ 
 
þ Dr½ 
dR½ 
d ½ 
 
 R½ 
D ½ 
  
FRD FDð Þ
Which is Expression 1
The notation and assumptions used to develop Expression 2, the inequality indicating when
resistance alleles will be inherited into offspring with an average fitness higher than
susceptible alleles, are similar to those used for the equivalent expression with respect to
deflection alleles.
Consider the allele pairs in gametes in the mating adult population:
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Rd½  ¼ proportion of resistance locus alleles which are resistance alleles paired with
non-deflection alleles in gametes
RD½  ¼ proportion of resistance locus alleles which are resistance alleles paired with
deflection alleles in gametes
rd½  ¼ proportion of resistance locus alleles which are susceptible alleles paired with
non-deflection alleles in gametes
rD½  ¼ proportion of resistance locus alleles which are susceptible alleles paired with
deflection alleles in gametes
R ½  ¼ proportion of resistance locus alleles in gametes which are resistance alleles
r ½  ¼ proportion of resistance locus alleles in gametes which are susceptible alleles
 d½  ¼ proportion of resistance locus alleles which are paired with non-deflection alleles in gametes
 D½  ¼ proportion of resistance locus alleles which are paired with deflection alleles in gametes
r ½ þ R ½  ¼  d½ þ  D½  ¼ 1
Let FR represent the average fitness of offspring into which resistance alleles are inherited:
FR ¼
1
R ½ 
Rd½  Rd½ FRþ Rd½  RD½ FRDþ Rd½  rd½ FRþ Rd½  rD½ FRD
þ RD½  Rd½ FRDþ RD½  RD½ FRDþ RD½  rd½ FRDþ RD½  rD½ FRD
 
FR ¼
1
R ½ 
Rd½  Rd½ þ Rd½  rd½ ð ÞFR
þ Rd½  RD½ þ Rd½  rD½  þ RD½  Rd½ þ RD½  RD½  þ RD½  rd½ þ RD½  rD½ ð ÞFRD
 
FR ¼
1
R ½  Rd½   d½ FRþ Rd½   D½ þ RD½ ð ÞFRDð Þ
FR ¼
1
R ½  Rd½   d½ FRþ R ½   D½ þ RD½   d½ ð ÞFRDð Þ
FR ¼
Rd½   d½ 
R ½ 
FR FSð Þþ  D½ þ
RD½   d½ 
R ½ 
 
FRD FSð ÞþFS
The average fitness of offspring into which susceptible alleles are inherited, Fr, is:
Fr ¼
1
r ½ 
rd½  Rd½ FRþ rd½  RD½ FRDþ rd½  rd½ FSþ rd½  rD½ FD
þ rD½  Rd½ FRDþ rD½  RD½ FRDþ rD½  rd½ FDþ rD½  rD½ FD
 
Fr ¼
1
r ½ 
rd½  Rd½ FRþ rd½  RD½ þ rD½  Rd½ þ rD½  RD½ ð ÞFRD
þ rd½  rd½ FSþ rd½  rD½  þ rD½  rd½ þ rD½  rD½ ð ÞFD
 
Fr ¼
rd½  Rd½ 
r ½ 
FRþ RD½ þ
rD½  Rd½ 
r ½ 
 
FRDþ
rd½  rd½ 
r ½ 
FSþ rD½  þ
rd½  rD½ ð Þ
r ½ 
 
FD
Fr ¼
rd½  Rd½ 
r ½ 
FR FSð Þþ RD½  þ
rD½  Rd½ 
r ½ 
 
FRD FSð Þþ rD½  þ
rd½  rD½ ð Þ
r ½ 
 
FD FSð ÞþFS
In order for the proportion of resistance alleles in the population to increase, we need the
average fitness of the offspring into which resistance alleles are inherited to be greater than
the average fitness of the offspring into which susceptible alleles are inherited. This is true
when the following inequality applies:
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FR >Fr $
Rd½   d½ 
R ½ 
FR FSð Þþ  D½  þ
RD½   d½ 
R ½ 
 
FRD FSð ÞþFS
 
rd½  Rd½ 
r ½ 
FR FSð Þ  RD½ þ
rD½  Rd½ 
r ½ 
 
FRD FSð Þ  rD½ þ
rd½  rD½ ð Þ
r ½ 
 
FD FSð Þ FS>0
$
Rd½   d½ 
R ½ 
 
Rd½  rd½ 
r ½ 
 
FR FDð Þþ
Rd½   d½ 
R ½ 
 
Rd½  rd½ 
r ½ 
  rD½  
rd½  rD½ ð Þ
r ½ 
 
FD FSð Þ
þ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FRD FRð Þþ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FR FDð Þ
þ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FD FSð Þ>0
$
Rd½   d½ 
R ½ 
 
Rd½  rd½ 
r ½ 
þ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FR FDð Þ
þ
Rd½   d½ 
R ½ 
 
Rd½  rd½ 
r ½ 
  rD½  
rd½  rD½ ð Þ
r ½ 
þ rD½ þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FD FSð Þ
þ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FRD FRð Þ>0
$ r ½ ð Þ FR FDð Þþ rd½  
rd½  rD½ ð Þ
r ½ 
 
FD FSð Þ
þ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FRD FRð Þ>0
$ rd½  FR FSð Þþ rD½  FR FDð Þ
þ rD½  þ
RD½   d½ 
R ½ 
 
rD½  Rd½ 
r ½ 
 
FRD FRð Þ>
rd½  rD½ ð Þ
r ½ 
FD FSð Þ
This is Expression 2.
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